A Review of Osteosarcoma-Derived Exosomes in Tumor Progression, Chemoresistance, and Bone Regeneration, and Their Potential in Drug Delivery
Medical Science Monitor · 02.11.2026 · 32
DOI: 10.12659/msm.953961 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medical Science Monitor, online erschienen am 02.11.2026. Verfasst von Peiyu Yan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, The Affiliated Hospital Yanbian University (Yanbian Hospital), Yanji, Jilin, China. Hauptthemen laut MEDLINE: Osteosarcoma, Exosomes, Bone Regeneration, Bone Neoplasms. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Clinical Laboratory, The Affiliated Hospital Yanbian University (Yanbian Hospital), Yanji, Jilin, China.
- Health Management (Medical Examination) Center, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
- Department of Dermatology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
- Medical Research Center, The Second Hospital of Jilin University, Changchun, Jilin, China.
Zitieren
APA
Yan, P., Yang, Q., Jin, A., & Piao, M. (2026). A Review of Osteosarcoma-Derived Exosomes in Tumor Progression, Chemoresistance, and Bone Regeneration, and Their Potential in Drug Delivery. Medical Science Monitor, 32. https://doi.org/10.12659/msm.953961
Vancouver
Yan P, Yang Q, Jin A, Piao M. A Review of Osteosarcoma-Derived Exosomes in Tumor Progression, Chemoresistance, and Bone Regeneration, and Their Potential in Drug Delivery. Medical Science Monitor. 2026;32. doi:10.12659/msm.953961
BibTeX
@article{Yan2026,
author = {Yan, Peiyu and Yang, Qiwei and Jin, Aihua and Piao, Meihua},
title = {A Review of Osteosarcoma-Derived Exosomes in Tumor Progression, Chemoresistance, and Bone Regeneration, and Their Potential in Drug Delivery},
journal = {Medical Science Monitor},
year = {2026},
volume = {32},
doi = {10.12659/msm.953961}
}
EUVIMED